Guolong Liao
Huizhou, 516000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The RNA-binding protein RBFOX2 suppresses colorectal cancer proliferation and metastasis by reducing FUBP1 mRNA stability to induce mitochondrial dysfunction and ferroptosis.
Journal: Discover oncology
Published: September 30, 2025
Conditional immortalization of mesenchymal stem cells and their extracellular vesicles therapy for interstitial cystitis/bladder pain syndrome.
Journal: Stem cell research & therapy
Published: April 23, 2025
The modified Devine procedure for penile reconstruction: A retrospective study of 80 cases.
Journal: Asian journal of urology
Published: November 25, 2024
MicroRNA-92a Inhibits the Cell Viability and Metastasis of Prostate Cancer by Targeting SOX4.
Journal: Technology in cancer research & treatment
Published: September 15, 2020
Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
Journal: Frontiers in oncology
Published: July 22, 2020
Selenium nanoparticles inhibit tumor metastasis in prostate cancer through upregulated miR-155-5p-related pathway.
Journal: Bioscience, biotechnology, and biochemistry
Published: July 08, 2020
Prepubertal-type teratoma in a postpubertal patient: case report and review of literature.
Journal: International journal of clinical and experimental pathology
Published: June 03, 2020
MiR-301a Promotes Cell Proliferation by Repressing PTEN in Renal Cell Carcinoma.
Journal: Cancer management and research
Published: March 11, 2020
Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16.
Journal: World journal of surgical oncology
Published: November 05, 2019
Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis.
Journal: Prostate cancer and prostatic diseases
Published: November 03, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026